Therapeutic Relevance of Inducing Autophagy in β-Thalassemia
Cells · 2024
DOI: 10.3390/cells13110918 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Roberto Gambari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center "Chiara Gemmo and Elio Zago" for the Research on Thalassemia, Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferr…. Hauptthemen laut MEDLINE: beta-Thalassemia, Autophagy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Italian Medicines Agency, European Union.
Abstract (Originalsprache)
The β-thalassemias are inherited genetic disorders affecting the hematopoietic system. In β-thalassemias, more than 350 mutations of the adult β-globin gene cause the low or absent production of adult hemoglobin (HbA). A clinical parameter affecting the physiology of erythroid cells is the excess of free α-globin. Possible experimental strategies for a reduction in excess free α-globin chains in β-thalassemia are CRISPR-Cas9-based genome editing of the β-globin gene, forcing “de novo” HbA production and fetal hemoglobin (HbF) induction. In addition, a reduction in excess free α-globin chains in β-thalassemia can be achieved by induction of the autophagic process. This process is regulated by the Unc-51-like kinase 1 (Ulk1) gene. The interplay with the PI3K/Akt/TOR pathway, with the activity of the α-globin stabilizing protein (AHSP) and the involvement of microRNAs in autophagy and Ulk1 gene expression, is presented and discussed in the context of identifying novel biomarkers and potential therapeutic targets for β-thalassemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center "Chiara Gemmo and Elio Zago" for the Research on Thalassemia, Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy.
ORCID-Profile: Roberto Gambari, Alessia Finotti
Förderung
- Wellcome Trust
- Italian Medicines Agency
- European Union
- FAR 2023
- Consorzio Interuniversitario per le Biotecnologie
- UE THALAMOSS Project
- FAR funds from the University of Ferrara
- Interuniversity Consortium for Biotechnology (CIB)
Zitieren
APA
Gambari, R., & Finotti, A. (2024). Therapeutic Relevance of Inducing Autophagy in β-Thalassemia. Cells. https://doi.org/10.3390/cells13110918
Vancouver
Gambari R, Finotti A. Therapeutic Relevance of Inducing Autophagy in β-Thalassemia. Cells. 2024. doi:10.3390/cells13110918
BibTeX
@article{Gambari2024,
author = {Gambari, Roberto and Finotti, Alessia},
title = {Therapeutic Relevance of Inducing Autophagy in β-Thalassemia},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13110918}
}
EUVIMED